The newly developed test by ErlySign, a biotech company from Nagpur, has been granted the US Food and Drug Administration (FDA) breakthrough device designation
@ChandnaHimani | #oralCancer
https://t.co/rIurAfLjUg
Grateful for the recognition!
This FDA Breakthrough Device Designation validates our team’s vision and highlights India’s capability to deliver world-class healthcare innovations. Excited for what’s ahead!
#MedTech#Innovation#IndiaRising#BiopharmaShakti
Thrilled to hear that our portfolio company #ErlySign, has received CDSCO approval for an active salivary biomarker study.
Link: https://t.co/CIHWzZYY3r
They come a step closer to availing a cost-friendly non-invasive swab test to detect #oralcancer.
Major Achievement Unlocked! Portfolio company #ErlySign secures CDSCO approval for active salivary biomarker study, a crucial step forward in their process to aid easy, non-invasive and affordable #cancer detection processes.
https://t.co/CXPwXgmDp0
#CancerScreening
BIO-PEOPLE: #ErlySign, the Nagpur-based #biotech#startup developing India’s first salivary #biomarker–based screening test for early-stage oral cancer, has announced the appointment of Vishal Kumar as Vice President – Business.
Details: https://t.co/0Z9BvUOsHp
#appointment
@AKPPL_Official@chay_akkineni@manavvij786@atul_kulkarni I really loved the movie. Initially had a prejudice from media feedback but when I watched the movie it was absolutely beautiful. I really loved it .. keep up Amir Khan.
THEY NEED YOU NOW MORE THAN EVER !!!
Please donate !! If you aren't able to donate, please share the post.
Link:- https://t.co/z2o762VkNw
Daily updates of the activity will be shared on NGO FB Page & Crowdfunding platform-Milaap.
#GoCorona#CoronaLockdown#COVID#covidindia